Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients.
about
Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections.Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa InfectionReview: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa.Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infectionSmall Colony Variants and Single Nucleotide Variations in Pf1 Region of PB1 Phage-Resistant Pseudomonas aeruginosaMonoclonal antibodies for prophylaxis and therapy of infectious diseases.Fluorescent cellular assay for screening agents inhibiting Pseudomonas aeruginosa adherence.Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infectionsMathematical modelling of the antibiotic-induced morphological transition of Pseudomonas aeruginosa.Resistance of Gram-Negative Bacilli in Lebanon
P2860
Q30443179-D1DBA03E-D638-434B-9E7C-684E210653DBQ33553646-C3E04066-018D-4AF3-B30A-74DCA0D71D67Q34999695-609864F2-C831-4D23-A9C4-22FF071864FBQ36161406-4D24BFF4-C4A2-4183-8A27-19A99D7308A4Q36665622-0E9F9FC1-63EC-4CE1-99A8-01E5FBB92484Q36989900-56CA69D4-F0A5-4520-9F33-1BBAE20276C7Q41558989-FEE989A2-A59B-476C-B735-AD43958C4C39Q42036438-6C66CDBB-3834-4878-82FA-BD881E36F250Q51738032-3F5DC169-4151-4192-BF1B-7815968AC715Q58998538-6BBC47F6-DBCC-437C-B314-9CF931ED991F
P2860
Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Prophylaxis and therapy of Pse ...... nd immunocompromised patients.
@en
type
label
Prophylaxis and therapy of Pse ...... nd immunocompromised patients.
@en
prefLabel
Prophylaxis and therapy of Pse ...... nd immunocompromised patients.
@en
P2093
P1433
P1476
Prophylaxis and therapy of Pse ...... nd immunocompromised patients.
@en
P2093
Adrian W Zuercher
Alois B Lang
Martin A Imboden
Michael P Horn
P356
10.1016/J.VACCINE.2004.08.016
P407
P478
22 Suppl 1
P577
2004-12-01T00:00:00Z